Michael Frumovitz
The University of Texas MD Anderson Cancer Center, Gynecologic Oncology Group
Papers
27
Total Citations
3,531
H-Index
19
About
Michael Frumovitz is a leading gynecologic oncologist whose research has fundamentally reshaped surgical practice for cervical and endometrial cancers. His most transformative contribution is the landmark 2018 study in the *New England Journal of Medicine*, which demonstrated that minimally invasive radical hysterectomy is associated with significantly lower survival rates compared to open abdominal surgery for early-stage cervical cancer. With nearly 1,900 citations, this practice-changing trial overturned a decade of surgical trends and sparked global re-evaluation of laparoscopic and robotic approaches. Frumovitz has continued to quantify these risks in subsequent high-impact studies (over 200 citations), solidifying his role as a critical voice in surgical oncology. Beyond cervical cancer, his work on lymphadenectomy patterns and surgical staging for endometrial cancer (135+ citations) has influenced clinical guidelines. He has also advanced the field through comprehensive reviews of minimally invasive techniques, including laparoendoscopic single-site surgery, and studies on surgical complications like vaginal cuff separation. With over 3,000 total citations across his most influential papers, Frumovitz’s research exemplifies how rigorous clinical trials can directly improve patient outcomes and challenge prevailing surgical dogma.
Research Focus
Key Achievements
Top Papers
- 1Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer1,859 citations · 2018
- 2
- 3
- 4Role of Minimally Invasive Surgery in Gynecologic Oncology142 citations · 2015
- 5
- 6
- 7
- 8
- 9
- 10